Sharon Grimster
Keine laufenden Positionen mehr
Profil
Sharon Grimster worked as a Director at Westerly Projects Ltd.
from 2004 to 2004.
She was the Head of Biologics Manufacturing Development at Celltech Group Plc and Vice President of Regulatory & Pharmaceutical at Antisoma Research Ltd.
She also worked as the General Manager for the Wales Region at ReNeuron Group Plc from 2015 to 2020 and as Vice President of Development at F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH.
Ms. Grimster completed her undergraduate degree at the University of Leicester.
Ehemalige bekannte Positionen von Sharon Grimster
| Unternehmen | Position | Ende |
|---|---|---|
| RENEURON GROUP PLC | Corporate Officer/Principal | 01.07.2020 |
| Westerly Projects Ltd. | Direktor/Vorstandsmitglied | 01.01.2004 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
| Antisoma Research Ltd. | General Counsel | - |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Ausbildung von Sharon Grimster
| University of Leicester | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RENEURON GROUP PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Westerly Projects Ltd. | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
| Antisoma Research Ltd. | |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
